Adaptive platform for pregnancy and newborn care
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study is a flexible platform that tests multiple experimental treatments for women at risk of preterm birth and for babies born prematurely. It aims to find better ways to improve outcomes for both mothers and newborns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and at risk of giving birth early (before 37 weeks).
- You are receiving care at a hospital that is taking part in this study.
- You meet the extra criteria for at least one of the study's treatment areas (your care team can check this).
- Your baby was born before 37 weeks (for the newborn part of the study).
- If you are considering the newborn part, you must be able to give consent for your baby.
- The study is not for cases where death is already considered certain and unavoidable, unless your care team decides participation could still help.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized care program to help reduce stress during pregnancy and prevent early birth. It is for pregnant women at higher risk of preterm birth and aims to improve health for both mother and baby.
This study looks at different care pathways to help lower the risk of preterm birth (birth too early). It will follow pregnant people with a singleton pregnancy to see which approaches may work best for preventing early delivery.
This study offers extra nutrition support during pregnancy through a digital platform, aiming to improve health for both you and your baby. You'll get personalized guidance beyond standard prenatal care.
This trial compares different antibiotics given to pregnant people whose waters break early (before 37 weeks) to prevent infection and improve outcomes. It aims to find the most effective antibiotic to protect both the parent and the baby.
This trial tests whether giving caffeine citrate early to very premature babies (born before 32 weeks) improves their breathing and long-term health. It aims to find the best way to use this common medicine to help your baby grow and develop.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
Hear when a new Preterm Birth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.